The Impact of Postoperative Prophylactic Medication on Long-Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease
Sebastiaan ten Bokkel Huinink, Michiel T. J. Bak, Evelien M. J. Beelen, Nicole S. Erler, Mark S. Silverberg, Matthieu Allez, Frank Hoentjen, Alexander G. L. Bodelier, Gerard Dijkstra, Marielle Romberg-Camps, Nanne K. H. de Boer, Laurents P. S. Stassen, Andrea E. van der Meulen – de Jong, Rachel L. West, C. Janneke van der Woude, Oddeke van Ruler, Annemarie C. de Vries
{"title":"The Impact of Postoperative Prophylactic Medication on Long-Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease","authors":"Sebastiaan ten Bokkel Huinink, Michiel T. J. Bak, Evelien M. J. Beelen, Nicole S. Erler, Mark S. Silverberg, Matthieu Allez, Frank Hoentjen, Alexander G. L. Bodelier, Gerard Dijkstra, Marielle Romberg-Camps, Nanne K. H. de Boer, Laurents P. S. Stassen, Andrea E. van der Meulen – de Jong, Rachel L. West, C. Janneke van der Woude, Oddeke van Ruler, Annemarie C. de Vries","doi":"10.1111/apt.18496","DOIUrl":null,"url":null,"abstract":"The impact of prophylactic medication following ileocecal resection (ICR) for Crohn's disease (CD) merits further elucidation. Prophylactic medication following ileocecal resection (ICR) is recommended in patients with Crohn’s disease (CD), particularly in patients at increased risk of recurrence, but the impact on long-term outcomes needs to be further elucidated.","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"13 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apt.18496","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The impact of prophylactic medication following ileocecal resection (ICR) for Crohn's disease (CD) merits further elucidation. Prophylactic medication following ileocecal resection (ICR) is recommended in patients with Crohn’s disease (CD), particularly in patients at increased risk of recurrence, but the impact on long-term outcomes needs to be further elucidated.
期刊介绍：
Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
